Sökning: onr:"swepub:oai:lup.lub.lu.se:46aeac07-d8ef-439b-95f3-a367bec2370a" >
Development, Valida...
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
-
- Krzyzanowska, Agnieszka (författare)
- Lund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Urological cancer, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments
-
- Barron, Stephen (författare)
- OncoAssure Ltd.
-
- Higgins, Debra F. (författare)
- OncoAssure Ltd.
-
visa fler...
-
Loughman, Tony (författare)
-
- O'Neill, Amanda (författare)
- University College Dublin
-
- Sheehan, Katherine M. (författare)
- Beaumont Hospital, Dublin
-
Wang, Chan Ju Angel (författare)
-
Fender, Bozena (författare)
-
McGuire, Leah (författare)
-
- Fay, Joanna (författare)
- Beaumont Hospital, Dublin
-
- O'Grady, Anthony (författare)
- Beaumont Hospital, Dublin
-
O'Leary, Des (författare)
-
- Watson, R. William (författare)
- University College Dublin
-
- Bjartell, Anders (författare)
- Lund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Urological cancer, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments
-
- Gallagher, William M. (författare)
- University College Dublin
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: European Urology Focus. - 2405-4569. ; 9:6, s. 983-991
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Molecular signatures in prostate cancer (PCa) tissue can provide useful prognostic information to improve the understanding of a patient's risk of harbouring aggressive disease. Objective: To develop and validate a gene signature that adds independent prognostic information to clinical parameters for better treatment decisions and patient management. Design, setting, and participants: Expression of 14 genes was evaluated in radical prostatectomy (RP) tissue from an Irish cohort of PCa patients (n = 426). A six-gene molecular risk score (MRS) was identified with strong prognostic performance to predict adverse pathology (AP) at RP or biochemical recurrence (BCR). The MRS was combined with the Cancer of the Prostate Risk Assessment (CAPRA) score, to create a molecular and clinical risk score (MCRS), and validated in a Swedish cohort (n = 203). Outcome measurements and statistical analysis: The primary AP outcome was assessed by the likelihood ratio statistics and area under the receiver operating characteristics curves (AUC) from logistic regression models. The secondary time to BCR outcome was assessed by likelihood ratio statistics and C-indexes from Cox proportional hazard regression models. Results and limitations: The six-gene signature was significantly (p < 0.0001) prognostic and added significant prognostic value to clinicopathological features for AP and BCR outcomes. For both outcomes, both the MRS and the MCRS increased the AUC/C-index when added to European Association of Urology (EAU) and CAPRA scores. Limitations include the retrospective nature of this study. Conclusions: The six-gene signature has strong performance for the prediction of AP and BCR in an independent clinical validation study. MCRS improves prognostic evaluation and can optimise patient management after RP. Patient summary: We found that the expression panel of six genes can help predict whether a patient is likely to have a disease recurrence after radical prostatectomy surgery.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- Molecular gene expression signature
- Prognosis
- Prostate cancer clinical patient management
- Risk stratification
- Treatment decisions
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Krzyzanowska, Ag ...
-
Barron, Stephen
-
Higgins, Debra F ...
-
Loughman, Tony
-
O'Neill, Amanda
-
Sheehan, Katheri ...
-
visa fler...
-
Wang, Chan Ju An ...
-
Fender, Bozena
-
McGuire, Leah
-
Fay, Joanna
-
O'Grady, Anthony
-
O'Leary, Des
-
Watson, R. Willi ...
-
Bjartell, Anders
-
Gallagher, Willi ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
European Urology ...
- Av lärosätet
-
Lunds universitet